
The global market for Next Generation Sequencing (NGS) Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Next Generation Sequencing (NGS) kits are a collection of reagents and consumables used in the process of DNA or RNA sequencing using Next Generation Sequencing technologies. NGS has numerous applications in various fields, including genomics, transcriptomics, epigenomics, metagenomics, and personalized medicine.
North American market for Next Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Next Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Next Generation Sequencing (NGS) Kits include Illumina, Bio-Rad Laboratories, BioCat GmbH, PerkinElmer, New England Biolabs, Isogen Life Science, TAKARA BIO, Thermo Fisher Scientific, Enzo Life Sciences, 10x Genomics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Kits.
The Next Generation Sequencing (NGS) Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next Generation Sequencing (NGS) Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencing (NGS) Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Illumina
Bio-Rad Laboratories
BioCat GmbH
PerkinElmer
New England Biolabs
Isogen Life Science
TAKARA BIO
Thermo Fisher Scientific
Enzo Life Sciences
10x Genomics
Cellecta
PCR Biosystems
Twist Bioscience
Agilent Technologies
Promega
Paragon Genomics
Nanjing Vazyme Biotech
Intact Genomics
Shanghai Yeasen Biotechnology
CD Genomics
Segment by Type
DNA Sequencing
RNA Sequencing
Others
Segment by Application
Biomedicine
Experimental Study
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next Generation Sequencing (NGS) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next Generation Sequencing (NGS) Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Next Generation Sequencing (NGS) Kits Market Overview
1.1 Product Definition
1.2 Next Generation Sequencing (NGS) Kits by Type
1.2.1 Global Next Generation Sequencing (NGS) Kits Market Value Comparison by Type (2024 VS 2031)
1.2.2 DNA Sequencing
1.2.3 RNA Sequencing
1.2.4 Others
1.3 Next Generation Sequencing (NGS) Kits by Application
1.3.1 Global Next Generation Sequencing (NGS) Kits Market Value by Application (2024 VS 2031)
1.3.2 Biomedicine
1.3.3 Experimental Study
1.3.4 Other
1.4 Global Next Generation Sequencing (NGS) Kits Market Size Estimates and Forecasts
1.4.1 Global Next Generation Sequencing (NGS) Kits Revenue 2020-2031
1.4.2 Global Next Generation Sequencing (NGS) Kits Sales 2020-2031
1.4.3 Global Next Generation Sequencing (NGS) Kits Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Next Generation Sequencing (NGS) Kits Market Competition by Manufacturers
2.1 Global Next Generation Sequencing (NGS) Kits Sales Market Share by Manufacturers (2020-2025)
2.2 Global Next Generation Sequencing (NGS) Kits Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Next Generation Sequencing (NGS) Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Next Generation Sequencing (NGS) Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Next Generation Sequencing (NGS) Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Next Generation Sequencing (NGS) Kits, Product Type & Application
2.7 Global Key Manufacturers of Next Generation Sequencing (NGS) Kits, Date of Enter into This Industry
2.8 Global Next Generation Sequencing (NGS) Kits Market Competitive Situation and Trends
2.8.1 Global Next Generation Sequencing (NGS) Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Next Generation Sequencing (NGS) Kits Players Market Share by Revenue
2.8.3 Global Next Generation Sequencing (NGS) Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Next Generation Sequencing (NGS) Kits Market Scenario by Region
3.1 Global Next Generation Sequencing (NGS) Kits Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Next Generation Sequencing (NGS) Kits Sales by Region: 2020-2031
3.2.1 Global Next Generation Sequencing (NGS) Kits Sales by Region: 2020-2025
3.2.2 Global Next Generation Sequencing (NGS) Kits Sales by Region: 2026-2031
3.3 Global Next Generation Sequencing (NGS) Kits Revenue by Region: 2020-2031
3.3.1 Global Next Generation Sequencing (NGS) Kits Revenue by Region: 2020-2025
3.3.2 Global Next Generation Sequencing (NGS) Kits Revenue by Region: 2026-2031
3.4 North America Next Generation Sequencing (NGS) Kits Market Facts & Figures by Country
3.4.1 North America Next Generation Sequencing (NGS) Kits Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Next Generation Sequencing (NGS) Kits Sales by Country (2020-2031)
3.4.3 North America Next Generation Sequencing (NGS) Kits Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Next Generation Sequencing (NGS) Kits Market Facts & Figures by Country
3.5.1 Europe Next Generation Sequencing (NGS) Kits Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Next Generation Sequencing (NGS) Kits Sales by Country (2020-2031)
3.5.3 Europe Next Generation Sequencing (NGS) Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Next Generation Sequencing (NGS) Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Next Generation Sequencing (NGS) Kits Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Next Generation Sequencing (NGS) Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific Next Generation Sequencing (NGS) Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Next Generation Sequencing (NGS) Kits Market Facts & Figures by Country
3.7.1 Latin America Next Generation Sequencing (NGS) Kits Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Next Generation Sequencing (NGS) Kits Sales by Country (2020-2031)
3.7.3 Latin America Next Generation Sequencing (NGS) Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Next Generation Sequencing (NGS) Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Next Generation Sequencing (NGS) Kits Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Next Generation Sequencing (NGS) Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa Next Generation Sequencing (NGS) Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Next Generation Sequencing (NGS) Kits Sales by Type (2020-2031)
4.1.1 Global Next Generation Sequencing (NGS) Kits Sales by Type (2020-2025)
4.1.2 Global Next Generation Sequencing (NGS) Kits Sales by Type (2026-2031)
4.1.3 Global Next Generation Sequencing (NGS) Kits Sales Market Share by Type (2020-2031)
4.2 Global Next Generation Sequencing (NGS) Kits Revenue by Type (2020-2031)
4.2.1 Global Next Generation Sequencing (NGS) Kits Revenue by Type (2020-2025)
4.2.2 Global Next Generation Sequencing (NGS) Kits Revenue by Type (2026-2031)
4.2.3 Global Next Generation Sequencing (NGS) Kits Revenue Market Share by Type (2020-2031)
4.3 Global Next Generation Sequencing (NGS) Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global Next Generation Sequencing (NGS) Kits Sales by Application (2020-2031)
5.1.1 Global Next Generation Sequencing (NGS) Kits Sales by Application (2020-2025)
5.1.2 Global Next Generation Sequencing (NGS) Kits Sales by Application (2026-2031)
5.1.3 Global Next Generation Sequencing (NGS) Kits Sales Market Share by Application (2020-2031)
5.2 Global Next Generation Sequencing (NGS) Kits Revenue by Application (2020-2031)
5.2.1 Global Next Generation Sequencing (NGS) Kits Revenue by Application (2020-2025)
5.2.2 Global Next Generation Sequencing (NGS) Kits Revenue by Application (2026-2031)
5.2.3 Global Next Generation Sequencing (NGS) Kits Revenue Market Share by Application (2020-2031)
5.3 Global Next Generation Sequencing (NGS) Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Illumina
6.1.1 Illumina Company Information
6.1.2 Illumina Description and Business Overview
6.1.3 Illumina Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Illumina Next Generation Sequencing (NGS) Kits Product Portfolio
6.1.5 Illumina Recent Developments/Updates
6.2 Bio-Rad Laboratories
6.2.1 Bio-Rad Laboratories Company Information
6.2.2 Bio-Rad Laboratories Description and Business Overview
6.2.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Rad Laboratories Next Generation Sequencing (NGS) Kits Product Portfolio
6.2.5 Bio-Rad Laboratories Recent Developments/Updates
6.3 BioCat GmbH
6.3.1 BioCat GmbH Company Information
6.3.2 BioCat GmbH Description and Business Overview
6.3.3 BioCat GmbH Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioCat GmbH Next Generation Sequencing (NGS) Kits Product Portfolio
6.3.5 BioCat GmbH Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Company Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 PerkinElmer Next Generation Sequencing (NGS) Kits Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 New England Biolabs
6.5.1 New England Biolabs Company Information
6.5.2 New England Biolabs Description and Business Overview
6.5.3 New England Biolabs Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 New England Biolabs Next Generation Sequencing (NGS) Kits Product Portfolio
6.5.5 New England Biolabs Recent Developments/Updates
6.6 Isogen Life Science
6.6.1 Isogen Life Science Company Information
6.6.2 Isogen Life Science Description and Business Overview
6.6.3 Isogen Life Science Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Isogen Life Science Next Generation Sequencing (NGS) Kits Product Portfolio
6.6.5 Isogen Life Science Recent Developments/Updates
6.7 TAKARA BIO
6.7.1 TAKARA BIO Company Information
6.7.2 TAKARA BIO Description and Business Overview
6.7.3 TAKARA BIO Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 TAKARA BIO Next Generation Sequencing (NGS) Kits Product Portfolio
6.7.5 TAKARA BIO Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Kits Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Enzo Life Sciences
6.9.1 Enzo Life Sciences Company Information
6.9.2 Enzo Life Sciences Description and Business Overview
6.9.3 Enzo Life Sciences Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Enzo Life Sciences Next Generation Sequencing (NGS) Kits Product Portfolio
6.9.5 Enzo Life Sciences Recent Developments/Updates
6.10 10x Genomics
6.10.1 10x Genomics Company Information
6.10.2 10x Genomics Description and Business Overview
6.10.3 10x Genomics Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 10x Genomics Next Generation Sequencing (NGS) Kits Product Portfolio
6.10.5 10x Genomics Recent Developments/Updates
6.11 Cellecta
6.11.1 Cellecta Company Information
6.11.2 Cellecta Description and Business Overview
6.11.3 Cellecta Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cellecta Next Generation Sequencing (NGS) Kits Product Portfolio
6.11.5 Cellecta Recent Developments/Updates
6.12 PCR Biosystems
6.12.1 PCR Biosystems Company Information
6.12.2 PCR Biosystems Description and Business Overview
6.12.3 PCR Biosystems Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.12.4 PCR Biosystems Next Generation Sequencing (NGS) Kits Product Portfolio
6.12.5 PCR Biosystems Recent Developments/Updates
6.13 Twist Bioscience
6.13.1 Twist Bioscience Company Information
6.13.2 Twist Bioscience Description and Business Overview
6.13.3 Twist Bioscience Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Twist Bioscience Next Generation Sequencing (NGS) Kits Product Portfolio
6.13.5 Twist Bioscience Recent Developments/Updates
6.14 Agilent Technologies
6.14.1 Agilent Technologies Company Information
6.14.2 Agilent Technologies Description and Business Overview
6.14.3 Agilent Technologies Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Agilent Technologies Next Generation Sequencing (NGS) Kits Product Portfolio
6.14.5 Agilent Technologies Recent Developments/Updates
6.15 Promega
6.15.1 Promega Company Information
6.15.2 Promega Description and Business Overview
6.15.3 Promega Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Promega Next Generation Sequencing (NGS) Kits Product Portfolio
6.15.5 Promega Recent Developments/Updates
6.16 Paragon Genomics
6.16.1 Paragon Genomics Company Information
6.16.2 Paragon Genomics Description and Business Overview
6.16.3 Paragon Genomics Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Paragon Genomics Next Generation Sequencing (NGS) Kits Product Portfolio
6.16.5 Paragon Genomics Recent Developments/Updates
6.17 Nanjing Vazyme Biotech
6.17.1 Nanjing Vazyme Biotech Company Information
6.17.2 Nanjing Vazyme Biotech Description and Business Overview
6.17.3 Nanjing Vazyme Biotech Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Nanjing Vazyme Biotech Next Generation Sequencing (NGS) Kits Product Portfolio
6.17.5 Nanjing Vazyme Biotech Recent Developments/Updates
6.18 Intact Genomics
6.18.1 Intact Genomics Company Information
6.18.2 Intact Genomics Description and Business Overview
6.18.3 Intact Genomics Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Intact Genomics Next Generation Sequencing (NGS) Kits Product Portfolio
6.18.5 Intact Genomics Recent Developments/Updates
6.19 Shanghai Yeasen Biotechnology
6.19.1 Shanghai Yeasen Biotechnology Company Information
6.19.2 Shanghai Yeasen Biotechnology Description and Business Overview
6.19.3 Shanghai Yeasen Biotechnology Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shanghai Yeasen Biotechnology Next Generation Sequencing (NGS) Kits Product Portfolio
6.19.5 Shanghai Yeasen Biotechnology Recent Developments/Updates
6.20 CD Genomics
6.20.1 CD Genomics Company Information
6.20.2 CD Genomics Description and Business Overview
6.20.3 CD Genomics Next Generation Sequencing (NGS) Kits Sales, Revenue and Gross Margin (2020-2025)
6.20.4 CD Genomics Next Generation Sequencing (NGS) Kits Product Portfolio
6.20.5 CD Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Next Generation Sequencing (NGS) Kits Industry Chain Analysis
7.2 Next Generation Sequencing (NGS) Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Next Generation Sequencing (NGS) Kits Production Mode & Process Analysis
7.4 Next Generation Sequencing (NGS) Kits Sales and Marketing
7.4.1 Next Generation Sequencing (NGS) Kits Sales Channels
7.4.2 Next Generation Sequencing (NGS) Kits Distributors
7.5 Next Generation Sequencing (NGS) Kits Customer Analysis
8 Next Generation Sequencing (NGS) Kits Market Dynamics
8.1 Next Generation Sequencing (NGS) Kits Industry Trends
8.2 Next Generation Sequencing (NGS) Kits Market Drivers
8.3 Next Generation Sequencing (NGS) Kits Market Challenges
8.4 Next Generation Sequencing (NGS) Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Illumina
Bio-Rad Laboratories
BioCat GmbH
PerkinElmer
New England Biolabs
Isogen Life Science
TAKARA BIO
Thermo Fisher Scientific
Enzo Life Sciences
10x Genomics
Cellecta
PCR Biosystems
Twist Bioscience
Agilent Technologies
Promega
Paragon Genomics
Nanjing Vazyme Biotech
Intact Genomics
Shanghai Yeasen Biotechnology
CD Genomics
Ìý
Ìý
*If Applicable.
